Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study.
Bleibtreu A, Dortet L, Bonnin RA, Wyplosz B, Sacleux SC, Mihaila L, Dupont H, Junot H, Bunel V, Grall N, Razazi K, Duran C, Tattevin P, Dinh A, The Cefiderocol French Study Group OBO. Bleibtreu A, et al. Among authors: junot h. Microorganisms. 2021 Jan 30;9(2):282. doi: 10.3390/microorganisms9020282. Microorganisms. 2021. PMID: 33573148 Free PMC article.
Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies.
Llopis B, Bleibtreu A, Schlemmer D, Robidou P, Paccoud O, Tissot N, Noé G, Junot H, Luyt CÉ, Funck-Brentano C, Zahr N. Llopis B, et al. Among authors: junot h. Clin Chem Lab Med. 2021 Jul 12;59(11):1800-1810. doi: 10.1515/cclm-2021-0423. Print 2021 Oct 26. Clin Chem Lab Med. 2021. PMID: 34243226
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
Amarsy R, Trystram D, Cambau E, Monteil C, Fournier S, Oliary J, Junot H, Sabatier P, Porcher R, Robert J, Jarlier V; “la Collégiale de Bactériologie–Virologie–Hygiène de l'Assistance Publique – Hôpitaux de Paris”. Amarsy R, et al. Among authors: junot h. Int J Infect Dis. 2022 Jan;114:90-96. doi: 10.1016/j.ijid.2021.10.034. Epub 2021 Oct 22. Int J Infect Dis. 2022. PMID: 34688945 Free PMC article.
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients.
Zahr N, Urien S, Llopis B, Noé G, Tissot N, Bihan K, Junot H, Marin C, Mansour B, Luyt CE, Bleibtreu A, Funck-Brentano C. Zahr N, et al. Among authors: junot h. Pharmaceutics. 2022 Dec 13;14(12):2786. doi: 10.3390/pharmaceutics14122786. Pharmaceutics. 2022. PMID: 36559279 Free PMC article.
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study.
Dinh A, Duran C, Singh S, Tesmoingt C, Bouabdallah L, Hamon A, Antignac M, Ourghanlian C, Loustalot MC, Pain JB, Wyplosz B, Junot H, Bleibtreu A, Michelon H; Temocillin Greater Paris Study Group. Dinh A, et al. Among authors: junot h. JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac132. doi: 10.1093/jacamr/dlac132. eCollection 2023 Feb. JAC Antimicrob Resist. 2022. PMID: 36601547 Free PMC article.
Corrigendum to "Pharmacokinetics/pharmacodynamics of ceftobiprole in patients on extracorporeal membrane oxygenation" [International Journal of Antimicrobial Agents Volume 61 (2023)106765].
Coppens A, Zahr N, Chommeloux J, Bleibtreu A, Hekimian G, Pineton de Chambrun M, LeFevre L, Schmidt M, Robert J, Junot H, Combes A, Luyt CE. Coppens A, et al. Among authors: junot h. Int J Antimicrob Agents. 2023 Jun;61(6):106814. doi: 10.1016/j.ijantimicag.2023.106814. Epub 2023 Apr 19. Int J Antimicrob Agents. 2023. PMID: 37084689 No abstract available.
22 results